Potential Benefits of Expanded Palivizumab in American Indian Children Under the Age of 2 Years

Ryan M. Close, Alvin S. Palmer,James B. Mcauley

Journal of the Pediatric Infectious Diseases Society（2023）

引用 0|浏览0

暂无评分

摘要

Severe respiratory syncytial virus (RSV) infections disparately impact American Indian communities. We implemented a program that expanded palivizumab to all children under 2 years of age that led to significant reductions in RSV infections and hospitalizations for both high-risk and non-high-risk recipients in a rural American Indian community in Eastern Arizona.

查看译文

关键词

palivizumab,american indian children,potential benefits

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要